Panagora Asset Management’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-19,809
Closed -$38K 2766
2019
Q2
$38K Sell
19,809
-256
-1% -$524 ﹤0.01% 2148
2019
Q1
$39K Hold
20,065
﹤0.01% 2108
2018
Q4
$30K Buy
20,065
+3,367
+20% +$6.74K ﹤0.01% 2123
2018
Q3
$39K Buy
16,698
+1,109
+7% +$2.39K ﹤0.01% 2079
2018
Q2
$42K Hold
15,589
﹤0.01% 2077
2018
Q1
$46K Buy
+15,589
New +$51.1K ﹤0.01% 2065
2015
Q3
Sell
-1,116
Closed -$88K 2481
2015
Q2
$88K Sell
1,116
-3,299
-75% -$222K ﹤0.01% 1990
2015
Q1
$299K Buy
+4,415
New +$284K ﹤0.01% 1518

Other funds holding FCSC

Panagora Asset Management's FCSC Position: Q3 2019 in Review

Panagora Asset Management sold out of Fibrocell Science Inc. (FCSC) in Q3 2019, closing a stake of 19,809 shares — an estimated $38K sold.

Panagora Asset Management first reported a position in FCSC in Q1 2015 and held it in 8 quarters. The position peaked at $299K in Q1 2015. 22 funds tracked by Wall St. Rank hold FCSC as of Q3 2019.

  • Panagora Asset Management reported no remaining Fibrocell Science Inc. position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 19,809 Fibrocell Science Inc. shares in Q3 2019, an estimated $38K.
  • Panagora Asset Management first reported a position in Fibrocell Science Inc. in Q1 2015 and held it in 8 quarters.
  • Panagora Asset Management's Fibrocell Science Inc. position peaked at $299K in Q1 2015.
  • 22 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.